{
  "zip": "2000",
  "sector": "Healthcare",
  "longBusinessSummary": "Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; B-Vaxx, a cancer vaccine to treat tumors that over-express the HER2/neu receptor; and CF-33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. Imugene Limited was incorporated in 1986 and is headquartered in Sydney, Australia.",
  "city": "Sydney",
  "phone": "61 3 9824 5254",
  "state": "NSW",
  "country": "Australia",
  "companyOfficers": [],
  "website": "http://www.imugene.com",
  "maxAge": 1,
  "address1": "37 Bligh Street",
  "industry": "Biotechnology",
  "address2": "Suite 1006 Level 10",
  "previousClose": 0.097,
  "regularMarketOpen": 0.081,
  "twoHundredDayAverage": 0.053019784,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.093,
  "navPrice": null,
  "averageDailyVolume10Day": 67863,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.097,
  "fiftyDayAverage": 0.08921677,
  "trailingAnnualDividendRate": null,
  "open": 0.081,
  "averageVolume10days": 67863,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.927987,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.081,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 52924,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 353889856,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 142184,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.081,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 52924,
  "fiftyTwoWeekHigh": 0.13,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.01,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 0.093,
  "exchange": "PNK",
  "shortName": "IMUGENE LIMITED",
  "longName": "Imugene Limited",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "IUGNF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_11113368",
  "uuid": "1cadf534-efa9-3439-bad0-57391ecaca1b",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": -2.54195,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 4740919808,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1593475200,
  "heldPercentInstitutions": 0.012200001,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.18413,
  "nextFiscalYearEnd": 1656547200,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 3630016835,
  "enterpriseValue": 435113984,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.081,
  "logo_url": "https://logo.clearbit.com/imugene.com"
}